Nuvation Stock Analysis

NUVB -  USA Stock  

USD 6.00  0.29  5.08%

The big decline in price over the last few months for Nuvation Biomay encourage investors to take a closer look at the firm as it is trading at a share price of 6.00 on 973,652 in trading volume. The company executives failed to add value to investors and positioning the firm supply of money to exploit market volatility in December. However, diversifying your holdings with Nuvation Bio or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.57. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Nuvation Bio partners.
Additionally, see Stocks Correlation.

Nuvation Stock Analysis 

The Nuvation Bio stock analysis report makes it easy to digest most publicly released information about Nuvation Bio and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Nuvation Stock analysis module also helps to analyze the Nuvation Bio price relationship with some important fundamental indicators such as market cap and management efficiency.

Nuvation Stock Analysis Notes

About 27.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.62. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nuvation Bio recorded a loss per share of 0.45. The entity had not issued any dividends in recent years. Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. Nuvation Bio Inc. was incorporated in 2018 and is headquartered in New York, New York. Nuvation Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 58 people. To find out more about Nuvation Bio contact David Hung at 332 208 6102 or learn more at

Nuvation Bio Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Nuvation Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Nuvation Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Nuvation Bio generated a negative expected return over the last 90 days
Nuvation Bio has high historical volatility and very poor performance
Nuvation Bio has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (97.62 M).
Nuvation Bio currently holds about 791.78 M in cash with (57.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.64.
Roughly 67.0% of the company shares are owned by institutional investors
Latest headline from Health Care Sector Update for 01202022 NUVB, NVAX, ARGX, XLV, IBB - Nasdaq

Nuvation Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Nuvation Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nuvation Bio backward and forwards among themselves. Nuvation Bio's institutional investor refers to the entity that pools money to purchase Nuvation Bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Fmr LlcCommon Shares32.1 M319.4 M
Omega Fund Management LlcCommon Shares28.2 M280.4 M
Ecor1 Capital LlcCommon Shares13.7 M136.3 M
Vanguard Group IncCommon Shares11.9 M118.3 M
Baupost Group LlcCommon Shares8.6 M85.4 M
Avidity Partners Management LpCommon Shares7.3 M72.2 M
Citadel Advisors LlcCommon Shares5.6 M56.1 M
Ecor1 Capital LlcWarrants963.3 K9.6 M
Note, although Nuvation Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Nuvation Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 1.25 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nuvation Bio's market, we take the total number of its shares issued and multiply it by Nuvation Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (10.79) % which means that it has lost $10.79 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (17.42) %, meaning that it created substantial loss on money invested by shareholders. Nuvation Bio management efficiency ratios could be used to measure how well nuvation bio manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 24th of January, Nuvation Bio secures the risk adjusted performance of (0.12), and Mean Deviation of 3.41. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nuvation Bio, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Nuvation Bio, which can be compared to its peers in the industry. Please verify Nuvation Bio jensen alpha, potential upside, as well as the relationship between the Potential Upside and skewness to decide if Nuvation Bio is priced some-what accurately, providing market reflects its recent price of 6.0 per share. Given that Nuvation Bio has jensen alpha of (0.66), we recommend you to check Nuvation Bio's last-minute market performance to make sure the company can sustain itself at a future point.

Nuvation Bio Price Movement Analysis

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Nuvation Bio price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator. View also all equity analysis or get more info about mesa adaptive moving average overlap studies indicator.

Nuvation Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nuvation Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nuvation Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nuvation Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Nuvation Bio Predictive Daily Indicators

Nuvation Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nuvation Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Nuvation Bio Forecast Models

Nuvation Bio time-series forecasting models is one of many Nuvation Bio's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nuvation Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Nuvation Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Nuvation Bio stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nuvation shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Nuvation Bio. By using and applying Nuvation Stock analysis, traders can create a robust methodology for identifying Nuvation entry and exit points for their positions.
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. Nuvation Bio Inc. was incorporated in 2018 and is headquartered in New York, New York. Nuvation Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 58 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Nuvation Bio to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Positions Ratings Now


Positions Ratings

Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module
Additionally, see Stocks Correlation. Note that the Nuvation Bio information on this page should be used as a complementary analysis to other Nuvation Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Piotroski F Score module to get Piotroski F Score based on binary analysis strategy of nine different fundamentals.

Complementary Tools for Nuvation Stock analysis

When running Nuvation Bio price analysis, check to measure Nuvation Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvation Bio is operating at the current time. Most of Nuvation Bio's value examination focuses on studying past and present price action to predict the probability of Nuvation Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nuvation Bio's price. Additionally, you may evaluate how the addition of Nuvation Bio to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Bond Directory
Find actively traded corporate debentures issued by US companies
Is Nuvation Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvation Bio. If investors know Nuvation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nuvation Bio is measured differently than its book value, which is the value of Nuvation that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvation Bio's value that differs from its market value or its book value, called intrinsic value, which is Nuvation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvation Bio's market value can be influenced by many factors that don't directly affect Nuvation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Nuvation Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.